Drug recall · August 31, 2022
Divalproex Sodium Extended Release Tablets recall
Why: Failed dissolution specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10
- Lots / codes
Lot #: AR210705, Exp 04/2024
- Quantity
- 4,309 bottles
- Company
- Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY
- Distribution
- USA nationwide
- Initiated
- July 27, 2022 · Voluntary: Firm initiated
- Classified
- August 19, 2022
- Reported
- August 31, 2022
- Ended
- August 17, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valproate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.